Default Rate

A Yale spinout's AI-powered EEG platform promises to prevent birth injuries and cut C-sections by monitoring the fetal brain, not just heart rate.

As Sri Lanka emerges from its economic crisis, a first-of-its-kind European-regulated fund provides a liquid, secure path to its undervalued assets.

A critical vulnerability in the OpenClaw AI agent allowed any website to silently hijack developer tools, exposing a new and dangerous class of security risks.

Top policymakers, including Dr. Agustín Carstens and FATF President Luis Urrutia Corral, will convene in Mérida to address critical cross-border tax issues.

Chinese data center giant VNET promotes Peter Zhang to SVP, signaling a focus on stability and governance as it navigates rapid AI-driven growth.

Anebulo Pharmaceuticals is delisting from Nasdaq to focus on a pediatric cannabis antidote, leaving investors to grapple with an uncertain future.

As Liberty Latin America preps its 2025 results, investors watch to see if strong subscriber growth and cost-cutting can sustain momentum in a competitive market.

After a major trial failure tanked its stock, Rezolute pins its hopes on a second drug program and a crucial FDA meeting to chart a path forward.

As AI pushes data centers to their limits, the optical industry gathers at OFC 2026 to unveil the power-efficient, high-speed networks of the future.

Lincoln International data reveals slowing growth and rising debt distress in private companies, a stark contrast to the heated M&A market for top assets.

A massive $313M federal funding win brings hope to the ALS community, pushing total investment past $1.6B. But how close are we to a real breakthrough?

For the seventh year, General Mills is one of America's most responsible companies. We explore the data, public trust, and strategy behind this major ESG achievement.

Exodus reports a surge in users and swap volume for January, defying a market downturn while strategically increasing its Solana treasury holdings.

A new deal for the rare isotope Actinium-225 could break a major supply bottleneck, accelerating the development of highly targeted cancer treatments.

With its foundational drug a success, Madrigal bets billions on next-gen siRNA tech, aiming to fuse it with Rezdiffra and dominate MASH treatment.

With French state backing, Eutelsat secures €1bn to build its next-gen OneWeb LEO constellation, intensifying the global satellite internet race.

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.

A national report card gives the U.S. a 'B' on rare disease policy, but stark state-by-state disparities leave millions vulnerable to financial ruin.

A spike in layoffs to 14-year highs clashes with extreme investor optimism, raising fears of a major market correction on the horizon for 2026.